I
Century Therapeutics D
D
IPSC
0.73620
USD
-0.01
(-0.88%)
مغلق
حجم التداول
3,181
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
62,598,381
المقالات
العنوان: Century Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.